Financial Sense Advisors Inc. lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 67.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,500 shares of the pharmacy operator's stock after selling 92,823 shares during the quarter. Financial Sense Advisors Inc.'s holdings in Walgreens Boots Alliance were worth $508,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently added to or reduced their stakes in the stock. Central Pacific Bank Trust Division lifted its stake in Walgreens Boots Alliance by 28.6% during the 1st quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock worth $50,000 after acquiring an additional 1,000 shares in the last quarter. Unison Advisors LLC lifted its stake in Walgreens Boots Alliance by 2.8% during the 4th quarter. Unison Advisors LLC now owns 43,226 shares of the pharmacy operator's stock worth $403,000 after acquiring an additional 1,168 shares in the last quarter. Avantax Advisory Services Inc. lifted its stake in Walgreens Boots Alliance by 2.4% during the 4th quarter. Avantax Advisory Services Inc. now owns 49,896 shares of the pharmacy operator's stock worth $466,000 after acquiring an additional 1,186 shares in the last quarter. Twelve Points Wealth Management LLC lifted its stake in Walgreens Boots Alliance by 4.5% during the 1st quarter. Twelve Points Wealth Management LLC now owns 27,837 shares of the pharmacy operator's stock worth $311,000 after acquiring an additional 1,199 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its stake in Walgreens Boots Alliance by 19.7% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 7,524 shares of the pharmacy operator's stock worth $84,000 after acquiring an additional 1,237 shares in the last quarter. Institutional investors own 58.59% of the company's stock.
Insider Buying and Selling at Walgreens Boots Alliance
In related news, Chairman Stefano Pessina bought 832,258 shares of the stock in a transaction on Sunday, April 27th. The shares were bought at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman owned 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. This trade represents a 0.57% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 17.50% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on WBA shares. UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Finally, Wall Street Zen began coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a "hold" rating on the stock. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $10.59.
Get Our Latest Stock Analysis on Walgreens Boots Alliance
Walgreens Boots Alliance Stock Performance
NASDAQ:WBA traded up $0.06 during mid-day trading on Thursday, reaching $11.59. 4,697,838 shares of the stock were exchanged, compared to its average volume of 16,586,406. The company has a 50 day simple moving average of $11.37 and a 200-day simple moving average of $11.07. The stock has a market capitalization of $10.03 billion, a P/E ratio of -1.59, a P/E/G ratio of 1.35 and a beta of 0.78. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $13.25.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.34 by $0.04. The firm had revenue of $38.99 billion for the quarter, compared to the consensus estimate of $36.72 billion. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%. The firm's quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.63 EPS. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
About Walgreens Boots Alliance
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.